Gilead Beats Earnings Expectations After Rocky Quarter

Gilead Beats Earnings Expectations After Rocky Quarter·Barrons.com
In this article:

The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.

Advertisement